Safety and clinical efficacy of the secretome of stressed peripheral blood mononuclear cells in patients with diabetic foot ulcer—study protocol of the randomized, placebo-controlled, double-blind, multicenter, international phase II clinical trial MARSYAS II

Safety and clinical efficacy of the secretome of stressed peripheral blood mononuclear cells in patients with diabetic foot ulcer—study protocol of the randomized, placebo-controlled, double-blind, multicenter, international phase II clinical trial MARSYAS II

Abstract Background Diabetes and its sequelae such as diabetic foot ulcer are rising health hazards not only in western countries but all over the world. Effective, yet safe treatments are desperately sought for by physicians, healthcare providers, and of course patients. Methods/design APOSEC, a no...

Full description

Bibliographic Details
Main Authors: Alfred Gugerell, Ghazaleh Gouya-Lechner, Helmut Hofbauer, Maria Laggner, Franz Trautinger, Gabriele Almer, Anja Peterbauer-Scherb, Marcus Seibold, Wolfram Hoetzenecker, Christiane Dreschl, Michael Mildner, Hendrik Jan Ankersmit
Format: Article
Language:English
Published: BMC 2021-01-01
Series:Trials
Subjects:
Diabetic foot ulcer
Secretome-based therapy
Peripheral blood mononuclear cells
Skin
Inflammation
(Impaired) wound healing
Online Access:https://doi.org/10.1186/s13063-020-04948-1

Internet

https://doi.org/10.1186/s13063-020-04948-1

Similar Items